pain
| 4 min read
For the first time, researchers observed new conformational states between opioid drugs binding to mu opioid receptors — findings that drug developers can use to design safer opioid drugs.
| 4 min read
Discover how ubrogepant provides migraine relief during the prodrome phase, easing symptoms before headaches fully develop.
| 4 min read
HHS decisions on COVID-19 and flu vaccines, new therapies with encouraging results for depression and ALS, and more industry news this week.
| 3 min read
New research shows a promising treatment for chronic back pain by targeting undying cells. Learn how senolytic drugs could revolutionize pain management.
| 5 min read
What’s stopping major progress in the development of new drugs right now? Biotech leaders and researchers shared their thoughts.
| 3 min read
A statistical model using two measures of brain activity could anticipate if people given an injection would be in severe pain for the next month.
| 3 min read
Vertex Pharmaceuticals’ drug, Journavx, blocks a sodium channel outside of the brain. Experts hope that this non-addictive pain drug may be the first of many.
| 3 min read
Researchers developed a new pill with promising applications for treating pain due to gastrointestinal disorders.
| 9 min read
Rodent studies and clinical trials increasingly demonstrate the soothing effects of green light, and now, researchers are revealing the underlying neural mechanisms.
| 3 min read
In rheumatoid arthritis, damaged joints contain fibroblasts that prompt nerve cell growth, potentially causing pain even in the absence of inflammation.
